20 Results

People

  1. Bacik
    Bacik
  2. Motzer
    Motzer
  3. Mazumdar
    Mazumdar
  4. Russo
    Russo
  5. Bajorin
    Bajorin
  6. Bosl
    Bosl
  7. Schwartz
    Schwartz
  8. Sheinfeld
    Sheinfeld
  9. Kondagunta
    Kondagunta
  10. Deluca
    Deluca

Groups

  1. Department of Medicine (18)
  2. Genitourinary Oncology Service (18)
  3. Solid Tumor Oncology Division (18)
  4. Surgery (12)
  5. Urology (12)
  6. Body Imaging Service (9)
  7. Radiology, Department of (9)
  8. Survivorship Research (7)
  9. Cell Biology Program Faculty (1)
  10. Hematologic Malignancies, Division of (1)
  1. "clinical trial"
  2. "Jennifer Bacik"
Formats
  1. Journal Article (20)
Groups
  1. Department of Medicine (18)
  2. Genitourinary Oncology Service (18)
  3. Solid Tumor Oncology Division (18)
  4. Surgery (12)
  5. Urology (12)
  6. Body Imaging Service (9)

More Groups

People
  1. Jennifer Bacik (20)
  2. Robert Motzer (18)
  3. Madhu Mazumdar (12)
  4. Gnanamba Kondagunta (8)
  5. George Bosl (7)
  6. Paul Russo (7)

More People

Years
  1. 2008 (1)
  2. 2007 (2)
  3. 2006 (3)
  4. 2005 (3)
  5. 2004 (6)
  6. 2003 (1)

More Years

Publications
  1. Journal of Clinical Oncology (11)
  2. Investigational New Drugs (4)
  3. Cancer (1)
  4. Health and Quality of Life Outcomes (1)
  5. JAMA - Journal of the American Medical Association (1)
  6. Molecular Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (11)
  2. Springer (5)
  3. Biomed Central Ltd (2)
  4. American Medical Association (1)
  5. Wiley Blackwell (1)

Results (20)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of lenalidomide in patients with metastatic renal cell carcinoma
    Journal Article

    Patel, P. H.; Kondagunta, G. V.; Schwartz, L.; Ishill, N.; Bacik, J.; Deluca, J.; Russo, P.; Motzer, R. J.
    Investigational New Drugs (2008)

    Fulltext@MSK | Save
  • Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors
    Journal Article

    Motzer, R. J.; Nichols, C. J.; Margolin, K. A.; Bacik, J.; Richardson, P. G.; Vogelzang, N. J.; Bajorin, D. F.; Lara, P. N. Jr; Einhorn, L.; Mazumdar, M.; more...
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Paclitaxel plus ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors
    Journal Article

    Kondagunta, G. V.; Bacik, J.; Sheinfeld, J.; Bajorin, D.; Bains, M.; Reich, L.; Deluca, J.; Budnick, A.; Ishill, N.; Mazumdar, M.; more...
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • A phase II trial of 17-(Allylamino)-17-demethoxygeldanamycin in patients with papillary and clear cell renal cell carcinoma
    Journal Article

    Ronnen, E. A.; Kondagunta, G. V.; Ishill, N.; Sweeney, S. M.; DeLuca, J. K.; Schwartz, L.; Bacik, J.; Motzer, R. J.
    Investigational New Drugs (2006)

    Fulltext@MSK | Save
  • Sunitinib in patients with metastatic renal cell carcinoma
    Journal Article

    Motzer, R. J.; Rini, B. I.; Bukowski, R. M.; Curti, B. D.; George, D. J.; Hudes, G. R.; Redman, B. G.; Margolin, K. A.; Merchan, J. R.; Wilding, G.; more...
    JAMA - Journal of the American Medical Association (2006)

    Fulltext@MSK | Save
  • A brief symptom index for advanced renal cell carcinoma
    Journal Article

    Eton, D. T.; Cella, D.; Bacik, J.; Motzer, R. J.
    Health and Quality of Life Outcomes (2006)

    Fulltext@MSK | Save
  • Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy
    Journal Article

    Ronnen, E. A.; Kondagunta, G. V.; Bacik, J.; Marion, S.; Bajorin, D. F.; Sheinfeld, J.; Bosl, G. J.; Motzer, R. J.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors
    Journal Article

    Kondagunta, G. V.; Bacik, J.; Donadio, A.; Bajorin, D.; Marion, S.; Sheinfeld, J.; Bosl, G. J.; Motzer, R. J.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Presentation and subsequent publication rates of phase I oncology clinical trials
    Journal Article

    Camacho, L. H.; Bacik, J.; Cheung, A.; Spriggs, D. R.
    Cancer (2005)

    Fulltext@MSK | Save
  • The functional assessment of cancer therapy-BRM (FACT-BRM): A new tool for the assessment of quality of life in patients treated with biologic response modifiers
    Journal Article

    Bacik, J.; Mazumdar, M.; Murphy, B. A.; Fairclough, D. L.; Eremenco, S.; Mariani, T.; Motzer, R. J.; Cella, D.
    Quality of Life Research (2004)

    Fulltext@MSK | Save